SEC Form 4 · accession 0001209191-15-024252
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Markus J. Cappel
Officer — Chief Bus. Officer & Treasurer
Period of report
Mar 5, 2015
Accepted (ET)
Mar 9, 2015 · 7:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 5, 2015 | M | 8,645 | $0.60 | A | 21,145 | D | |
| Common StockF2,F3 | Mar 5, 2015 | S | 8,645 | $7.9895 | D | 12,500 | D | |
| Common Stock | Mar 6, 2015 | M | 17,721 | $0.60 | A | 30,221 | D | |
| Common StockF2,F4 | Mar 6, 2015 | S | 17,721 | $7.7578 | D | 12,500 | D | |
| Common Stock | Mar 9, 2015 | M | 7,759 | $0.60 | A | 20,259 | D | |
| Common StockF2,F5 | Mar 9, 2015 | S | 7,759 | $7.7431 | D | 12,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F7,F6 | $0.60 | Mar 5, 2015 | M | 8,645 | D | May 5, 2005 | May 5, 2015 | Common Stock | 8,645 | 25,480 | D |
| Stock Option (right to buy)F7,F6 | $0.60 | Mar 6, 2015 | M | 17,721 | D | May 5, 2005 | May 5, 2015 | Common Stock | 17,721 | 7,759 | D |
| Stock Option (right to buy)F7,F6 | $0.60 | Mar 9, 2015 | M | 7,759 | D | May 5, 2005 | May 5, 2015 | Common Stock | 7,759 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2Shares sold are associated with stock options which will expire in May 2015.
- F3Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.89 to $8.14 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- F4Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.64 to $7.90 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- F5Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.66 to $7.85 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- F6As of March 5, 2015 and prior to this transaction, the option fully vested.
- F7Not applicable.